Our results showed a noticeable downregulation of CD46 mCRP in both acute leukemia types, ALL and AML compared to healthy controls where in AML samples CD46 expression was downregulated by 4 fold and in ALL it was downregulated by 5.5 fold compared to expression in healthy controls. Here, CD46 is linked to acute leukemia.